Skip to search formSkip to main contentSkip to account menu

Tarceva

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Erlotinib Hydrochlorideerlotinib
erlotinib 100 MG Oral Tablet [Tarceva]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Hand–foot syndrome induced by erlotinib (TarcevaⓇ)
Several adverse reactions have been described in the literature. These are similar to the features of anaphylaxis and… 
2011
2011
Deliberating Tarceva: A case study of how British NHS managers decide whether to purchase a high-cost drug in the shadow of NICE guidance.
2009
2009
Clinical study of tarceva in combination with Xiaoyantang plus-minus prescriptions in treatment of non-small cell lung cancer
Objective:To observe tarceva combined with xiaoyantang plus-minus prescriptions in treatment of non-small cell lung cancer… 
2009
2009
Avastin-Tarceva combination fails in lung cancer
2009
2009
Long-Term Treatment of Advanced Hepatocellular Carcinoma with the Tyrosine Kinase Inhibitor Erlotinib (Tarceva®) – A Case Report
Hintergrund: Patient und Methoden: Ergebnisse: Schlussfolgerung: Aim: Patient and Methods: Results: Conclusions. 
2008
2008
Targeted combinatorial therapy of non‐small cell lung carcinoma using a GST‐fusion protein of full‐length or truncated MDA‐7/IL‐24 with Tarceva
Melanoma differentiation associated gene‐7/interleukin‐24 (mda‐7/IL‐24), a cytokine belonging to the IL‐10 family, displays… 
2008
2008
A phase I study of PEG-intron, sunitinib and tarceva in patients with metastatic renal cell cancer (MRCC)
14659 Background: Renal cell cancer (RCC) frequently overexpresses basic vascular endothelial growth factor, epithelial growth… 
2005
2005
Overcoming Acquired Resistance to Iressa/Tarceva with Inhibitors of a Different Class
Small molecule kinase inhibitors of the epidermal growth factor receptor (EGFR) have recently been found to exhibit clinical… 
2004
2004
Erlotinib (Tarceva ® ) inhibits oral cavity carcinoma and synergizes with cisplatin and ionizing radiation in vitro
Epidermal growth factor (EGF) plays important roles in the growth and development of normal epidermis and numerous malignant… 
2004
2004
Erlotinib given sequentially to capecitabine and vinorelbine as first-second line chemotherapy in metastatic breast cancer patients. A dose finding study.
834 Background: The combination of capecitabine (C) and vinorelbine (V) is active and has an acceptable toxicity profile in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)